Enteris BioPharma Inc.
Aptar Pharma is a leading drug delivery expert supporting pharmaceutical companies worldwide with innovative solutions, services, and technologies to develop safe, efficient, and compliant medicines. The company emphasizes innovation, quality, global manufacturing, and local support, aiming to improve patient outcomes and support the pharmaceutical industry's evolving needs. They offer a broad range of drug delivery systems, including inhalers, nasal systems, dermal solutions, and preclinical research kits, with a focus on advancing drug delivery routes and technologies. Their extensive portfolio includes innovative technologies such as active material science, airless systems, preservative-free systems, bag-on-valve, child-resistant and senior-friendly solutions, and a wide range of delivery routes including nasal, inhalation, injectables, eye care, dermal, oral liquid, and others. They have a global manufacturing footprint with 15 GMP sites, manufacturing 8 billion systems annually for over 1,500 customers, supported by a worldwide salesforce, regulatory experts, scientists, and customer service teams. The company has a proven track record of supporting over 800 prescription products and has received awards such as the InnoPack China Awards. Recent innovations include digital healthcare solutions, precision inhalation systems like Kolibri, and sustainable packaging solutions. Aptar Pharma is committed to quality, innovation, and customer success, aiming to deliver complete drug delivery solutions that improve patient outcomes and maximize market opportunities.
Industries
Nr. of Employees
Very Large (1000+)
Products
Recyclable nasal spray pump (multidose)
Multidose nasal spray pump designed for recyclable materials and reduced environmental impact for repeated intranasal dosing.
Bidose liquid nasal spray system
Two‑dose nasal spray system enabling separate dosing events from a single unit for intranasal administration.
Ophthalmic multidose preservative‑free dispenser
Multidose eye‑drop dispenser platform designed to enable preservative‑free ophthalmic administration with validated sterility maintenance.
Airless dermal dispenser with circular design options
Airless dispensing platform for semi‑solid dermal formulations with options for mono‑material closures and certified recyclability.
Bag‑on‑valve multidose dispenser
Bag‑on‑valve dispenser platform for continuous, preservative‑protecting dispensing of liquid products in multidose formats.
Multidose spray pump platforms (multi‑format)
Range of multidose spray pump platforms engineered for nasal and topical delivery across different dose volumes and actuation profiles.
Recyclable nasal spray pump (multidose)
Multidose nasal spray pump designed for recyclable materials and reduced environmental impact for repeated intranasal dosing.
Bidose liquid nasal spray system
Two‑dose nasal spray system enabling separate dosing events from a single unit for intranasal administration.
Ophthalmic multidose preservative‑free dispenser
Multidose eye‑drop dispenser platform designed to enable preservative‑free ophthalmic administration with validated sterility maintenance.
Airless dermal dispenser with circular design options
Airless dispensing platform for semi‑solid dermal formulations with options for mono‑material closures and certified recyclability.
Bag‑on‑valve multidose dispenser
Bag‑on‑valve dispenser platform for continuous, preservative‑protecting dispensing of liquid products in multidose formats.
Multidose spray pump platforms (multi‑format)
Range of multidose spray pump platforms engineered for nasal and topical delivery across different dose volumes and actuation profiles.
Services
End‑to‑end support covering device and formulation development, analytical testing, clinical trial support, regulatory filings and market launch activities to accelerate and derisk drug‑device programmes.
Specialised R&D, analytical testing and cGMP support for intranasal and inhaled drug products including in‑vitro/in‑silico modelling, PBPK simulations, in‑vitro bioequivalence support and particle characterisation.
Regulatory‑grade laboratory services for injectable products including particulate analysis, container‑closure integrity testing and extractables & leachables assessments.
Human factors studies, healthcare professional training, patient onboarding strategies and adherence programmes to support real‑world use and adoption of combination products.
Regulatory strategy and documentation support for drug‑device combination products, including testing plans and regional submission pathways.
Design and development of mobile apps, cloud platforms, connected devices and digital therapeutics with GDPR/HIPAA‑aligned data processing and ISO‑aligned quality systems.
End‑to‑end support covering device and formulation development, analytical testing, clinical trial support, regulatory filings and market launch activities to accelerate and derisk drug‑device programmes.
Specialised R&D, analytical testing and cGMP support for intranasal and inhaled drug products including in‑vitro/in‑silico modelling, PBPK simulations, in‑vitro bioequivalence support and particle characterisation.
Regulatory‑grade laboratory services for injectable products including particulate analysis, container‑closure integrity testing and extractables & leachables assessments.
Human factors studies, healthcare professional training, patient onboarding strategies and adherence programmes to support real‑world use and adoption of combination products.
Regulatory strategy and documentation support for drug‑device combination products, including testing plans and regional submission pathways.
Design and development of mobile apps, cloud platforms, connected devices and digital therapeutics with GDPR/HIPAA‑aligned data processing and ISO‑aligned quality systems.
Expertise Areas
- Multidose dispensing systems across nasal, dermal, ophthalmic and oral routes
- Pulmonary and inhalation delivery systems
- Container‑closure systems and sterile syringe components for injectables
- Preservative‑free multidose ophthalmic delivery
Key Technologies
- Airless dispensing technology
- Bag‑on‑valve dispensing systems
- Bidose nasal spray systems
- Multidose spray pump platforms
News & Updates
Event on June 4, 2025.
Partnership announced on May 22, 2025.
Webinar held on April 28, 2025.
Event on May 16, 2023.
Award received on January 23, 2023.
Event on January 16, 2023.
Event on June 4, 2025.
Partnership announced on May 22, 2025.
Webinar held on April 28, 2025.
Event on May 16, 2023.
Award received on January 23, 2023.
Event on January 16, 2023.